SFDA-2023-0097-V297
Type II variation for application SFDA-2023-0097. Type II variation: Specification Change for Lecanemabix — routine update
Variation Number
SFDA-2023-0097-V297
Type
Type II
Application
Change
Status
Failed
Fee
€20,239
Submitted
2023-11-25
Approved
—
Description
Type II variation: Specification Change for Lecanemabix — routine update